IL 9 Rat

Interleukin-9 Rat Recombinant
Shipped with Ice Packs
In Stock

Description

Biological Functions

IL-9 Rat mediates immune responses through interactions with the IL-9 receptor (IL-9R), composed of IL-9Rα and the common gamma chain (γc). Key roles include:

Immune Cell Regulation

  • T Cells: Promotes Th9 differentiation and enhances IL-9-dependent T-cell proliferation .

  • Mast Cells/Basophils: Drives survival, proliferation, and cytokine production (e.g., histamine) in allergic responses .

  • B Cells: Supports immunoglobulin production and humoral immunity .

  • Regulatory T Cells (Tregs): Enhances suppressive activity via STAT3/STAT5 signaling .

Disease Associations

ConditionRole of IL-9 RatCitations
AsthmaTransgenic overexpression induces eosinophilic lung inflammation .
Myasthenia GravisNeutralizing IL-9 reduces disease severity in experimental autoimmune models .
CancerDual role: promotes hematologic malignancies but inhibits melanoma growth .

Signaling Pathways

IL-9 Rat activates the JAK-STAT cascade, with downstream effects on gene transcription:

Pathway ComponentFunction
JAK1/JAK3Kinases activated upon IL-9R binding .
STAT1/STAT3/STAT5Transcription factors driving cell proliferation and survival .
MAPK/PI3KSecondary pathways modulating immune cell responses .

Experimental Tools

  • ELISA Kits: Quantify IL-9 in serum, plasma, or supernatants (e.g., Invitrogen ERA34RB) .

  • Recombinant Proteins: Used in vitro to study Th9 differentiation, mast cell activation, and Treg modulation .

Disease Models

  • Allergic Lung Inflammation: IL-9 overexpression in transgenic mice induces airway hyperresponsiveness and eosinophilia .

  • Parasitic Infections: Enhances immunity to Trichuris muris but exacerbates Leishmania major susceptibility .

Clinical and Therapeutic Insights

  • Asthma: IL-9 amplifies IL-13-dependent mucus production and airway remodeling .

  • Autoimmunity: Blocking IL-9 reduces symptoms in myasthenia gravis and experimental autoimmune encephalomyelitis (EAE) .

  • Cancer: Context-dependent roles necessitate targeted therapies (e.g., IL-9 inhibition in Hodgkin’s lymphoma vs. augmentation in melanoma) .

Production Methods

Expression SystemAdvantagesLimitations
E. coliHigh yield, cost-effectiveLack of glycosylation
NS0 CellsProper glycosylation, bioactive conformationHigher production costs

Future Directions

Ongoing research focuses on IL-9 Rat's dual roles in immunity and pathology, with emphasis on:

  • Th9 Cell Plasticity: Regulatory mechanisms driving IL-9 production in autoimmune contexts .

  • Therapeutic Targeting: Neutralizing antibodies or agonists for asthma, cancer, and neuroinflammatory diseases .

Product Specs

Introduction
Interleukin-9 (IL-9) is believed to play a role in regulating hematopoiesis, the formation of blood cellular components. Studies have demonstrated its ability to promote the growth of various cells, including human mast cells, megakaryoblastic leukemic cells, and murine helper T-cell clones. This glycoprotein, with a molecular weight ranging from 32 to 39 kDa, originates from T-cells and is located on chromosome 5 in humans.
Description
Recombinant Rat Interleukin-9, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 127 amino acids, resulting in a molecular weight of 14.3 kDa. The purification process of IL-9 involves proprietary chromatographic techniques.
Physical Appearance
White, lyophilized (freeze-dried) powder, sterile and filtered.
Formulation
The IL-9 protein was lyophilized from a 0.2 μm filtered solution concentrated in PBS at a pH of 7.4.
Solubility
For reconstitution of the lyophilized Interleukin-9, it is advised to use sterile 18 MΩ-cm H2O at a concentration not less than 100 μg/ml. This solution can be further diluted in other aqueous solutions.
Stability
Lyophilized Interleukin-9, though stable at room temperature for a period of 3 weeks, is best stored in dry conditions below -18°C. After reconstitution, IL-9 should be stored at 4°C for 2-7 days. For extended storage, freezing the solution below -18°C is recommended. To ensure optimal stability during long-term storage, adding a carrier protein (0.1% HSA or BSA) is advisable. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 97.0% through the following analyses: (a) Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and (b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE).
Biological Activity
The ED50, determined by a cell proliferation assay using murine TS1 cells, is less than 10 ng/ml. This corresponds to a specific activity exceeding 1.0 × 105 IU/mg.
Synonyms
Interleukin 9, Protein Il9, Il9.
Source
Escherichia Coli.
Amino Acid Sequence
MQRCSTSWGI QHTSYLIENL KDDPSSKCSC SANVTSCLCL PIPSDDCTTP CFQEGMSQVT NATQQSKFSP FFFRVKRIVE TLKSNKCQFF SCEKPCNQTT AGNTVSFLKS LLKTFQKTEV QVQRSRA.

Q&A

What is rat IL-9 and what are its essential biological characteristics?

Rat Interleukin-9 (IL-9) is a 20-30 kDa secreted glycoprotein belonging to the IL-7/IL-9 family of hematopoietic cytokines . It is primarily produced by activated T helper 2 (Th2) lymphocytes and functions as a regulatory cytokine in various immunological processes . The rat IL-9 cDNA encodes a 144 amino acid precursor protein with an 18 amino acid signal peptide that is cleaved to form the mature cysteine-rich protein with a molecular mass of approximately 14 kDa, though the native protein is heavily glycosylated . The gene identifier for rat IL-9 is 116558 with the gene symbol Il9, and protein aliases include ILN, Interleukin, Interleukin9, and interleukin-9 .

How does rat IL-9 compare to mouse and human IL-9?

While the search results do not provide extensive comparative data, they indicate similarities between rat and mouse IL-9. Like mouse IL-9, rat IL-9 appears to function in T-cell differentiation and immune regulation. Both species have IL-9 proteins that undergo post-translational modifications, particularly glycosylation, which affects their molecular weight and functional properties . Research indicates that findings on IL-9-secreting TH9 cells have antitumor properties in both mouse and human cancers, suggesting conserved functional roles across species .

What cell types produce IL-9 in rats?

The primary source of IL-9 in rats is activated T helper 2 (Th2) lymphocytes . More recently, a distinct subset of CD4+ T cells called TH9 cells has been identified as specialized producers of IL-9 . These cells differentiate from naive CD4 T cells when stimulated with transforming growth factor beta (TGF-β) and IL-4 . Additionally, research has shown that TGF-β can reprogram existing Th2 cells to secrete IL-9, effectively converting them to TH9 cells .

What techniques are available for detecting IL-9 in rat samples?

Several validated methods exist for detecting IL-9 in rat samples:

ELISA Assays: Rat IL-9 ELISA kits can quantitate IL-9 in rat serum, plasma, and cell culture supernatants . These assays recognize both natural and recombinant rat IL-9 with high specificity.

Flow Cytometry: Flow cytometric analysis using anti-rat IL-9 antibodies can detect intracellular IL-9 in rat cells. This typically requires cell fixation with paraformaldehyde and permeabilization with saponin . For optimal results, cells may need stimulation with agents such as PMA (phorbol 12-myristate 13-acetate) and calcium ionophore.

Reporter Systems: While not explicitly mentioned for rats, reporter systems like IL-9-GFP have been used in mouse models and could potentially be adapted for rat studies .

How should I prepare rat samples for optimal IL-9 detection?

For flow cytometry detection of intracellular IL-9, rat splenocytes should be treated with appropriate stimulants (e.g., 50 ng/mL PMA and 500 ng/mL Ca2+ ionophore for 24 hours), followed by fixation with paraformaldehyde and permeabilization with saponin before staining with anti-IL-9 antibodies . For ELISA assays, sample preparation will depend on the specific kit instructions, but generally involves collection of serum, plasma, or cell culture supernatants under sterile conditions .

What controls are essential when measuring IL-9 in rat experiments?

When conducting antibody-based detection methods such as flow cytometry, appropriate isotype controls are essential. For anti-rat IL-9 antibodies, a suitable control would be rat IgG1 isotype control (such as clone HRPN) . In neutralization experiments, including both the neutralizing antibody and appropriate isotype controls is critical for result interpretation . When using fluorescently labeled secondary antibodies, include controls with secondary antibody alone to account for non-specific binding .

What are the primary biological functions of IL-9 in rats?

IL-9 in rats serves several important immunoregulatory functions:

  • Regulates multiple cell types involved in Th2-associated asthma responses, including B and T lymphocytes, mast cells, eosinophils, and epithelial cells

  • Plays a critical role in the antitumor functions of TH9 cells, as demonstrated in adoptive transfer experiments

  • Contributes to TH9 cell-mediated immune responses, which are essential for the efficacy of certain cancer immunotherapy treatments such as dendritic cell vaccination and anti-GITR therapy

How is IL-9 production regulated in rat immune cells?

IL-9 production in rats is regulated by a complex network of cytokines and signaling pathways. TGF-β plays a particularly important role, reprogramming Th2 cells to secrete IL-9 and driving the differentiation of TH9 cells . The combination of TGF-β and IL-4 stimulates the differentiation of naive CD4 T cells into IL-9-producing TH9 cells . Proinflammatory factors, including IL-1β and tumor necrosis factor alpha (TNF-α), enhance TH9 differentiation and subsequent IL-9 production . Additionally, recent evidence suggests that STING (Stimulator of Interferon Genes) signaling may influence T cell differentiation and potentially IL-9 production, though the exact mechanism needs further investigation .

What is the functional relationship between IL-9 and TH9 cells in rat models?

TH9 cells are specialized CD4+ T cells that produce high levels of IL-9 . These cells exert IL-9-mediated antitumor functions when adoptively transferred into tumor-bearing mice, suggesting IL-9 is the primary mediator of their anticancer activity . In experimental settings, TH9 cells stimulated with cyclic GMP-AMP synthase (cGAMP) before in vitro polarization showed enhanced antitumor efficacy when adoptively transferred into B16-OVA tumor-bearing mice . This indicates that manipulating TH9 cells can modulate IL-9 production and subsequent antitumor functions.

How is IL-9 involved in rat models of asthma and allergic inflammation?

IL-9 regulates multiple cell types involved in Th2-associated asthma responses, including B and T lymphocytes, mast cells, eosinophils, and epithelial cells . While the search results don't provide specific experimental details for rat asthma models, the involvement of IL-9 in regulating these cell types suggests its importance in allergic airway inflammation. Understanding IL-9's role in these models can provide insights into potential therapeutic targets for asthma and allergic conditions.

What is the role of IL-9 in rat cancer models?

IL-9, primarily through TH9 cells, demonstrates significant antitumor properties in experimental cancer models . When adoptively transferred into tumor-bearing mice, IL-9-secreting TH9 cells exert potent antitumor functions . The experimental protocol typically involves:

  • Establishing tumors (e.g., B16-OVA melanoma) in mice

  • Generating and potentially manipulating TH9 cells in vitro

  • Adoptively transferring 2×10^6 effector TH9 cells intravenously

  • Monitoring tumor growth by measuring tumor dimensions three times weekly

In lung metastasis models, 2.5×10^5 B16-OVA cells are injected intravenously, followed by TH9 cell transfer one day later, with lung tumor foci enumerated 14 days post-transfer .

How can IL-9-producing cells be used in adoptive transfer experiments?

The following protocol outlines a method for using IL-9-producing TH9 cells in adoptive transfer experiments:

  • Generate effector TH9 cells from naive CD4 T cells (e.g., from OT-II transgenic mice) by stimulating with TGF-β and IL-4

  • Optionally stimulate cells with cGAMP or other agents before in vitro polarization to enhance their function

  • Inject 2×10^6 effector TH9 cells intravenously into tumor-bearing recipients (typically 5 days after subcutaneous tumor implantation)

  • Monitor tumor growth by measuring dimensions three times weekly, euthanizing mice when tumors exceed 300 mm^2 or become ulcerated

For intravenous tumor models, inject tumor cells first, followed by TH9 cell transfer one day later, and evaluate outcomes after 14 days .

How can I establish IL-9 neutralization in rat experimental models?

While the search results don't provide rat-specific protocols, neutralizing antibodies against IL-9 can be used with appropriate isotype controls, such as rat IgG1 isotype control (clone HRPN, BioXCell) . When designing neutralization experiments, consider:

  • Determining appropriate antibody dosage through dose-response studies

  • Including proper isotype controls at equivalent concentrations

  • Validating neutralization efficiency through functional assays

  • Administering antibodies at time points relevant to the experimental question

The effectiveness of neutralization should be verified through downstream measurements of IL-9-dependent activities.

What factors should be considered when studying IL-9 in the context of STING signaling?

Recent research highlights the importance of STING (Stimulator of Interferon Genes) signaling in T cell differentiation and function . When studying IL-9 in relation to STING signaling, several factors should be considered:

  • Use of appropriate genetic models, such as Sting1^-/- or STING V154M/WT mice, which could be adapted or compared to rat models

  • Investigation of how STING agonists like cGAMP affect TH9 cell differentiation and IL-9 production

  • Consideration of the interplay between STING, type I interferon signaling, and IL-9 production, potentially using Ifnar^-/- models

  • Assessment of how STING signaling affects the antitumor functions of IL-9-producing cells in vivo

How should researchers interpret conflicting data on IL-9 functions?

When confronted with conflicting data on IL-9 functions, researchers should:

  • Carefully evaluate the experimental systems used, as IL-9 function may be context-dependent

  • Consider strain differences in rats, as genetic background can influence cytokine responses

  • Examine the specific cell types and activation conditions used, as these can dramatically affect IL-9 production and function

  • Assess the presence of other cytokines in the experimental system, as cytokine networks involve complex interactions

  • Compare in vitro versus in vivo results, recognizing that cell culture findings may not always translate to whole animal models

  • Verify antibody specificity and detection method sensitivity, as technical variations can lead to apparently conflicting results

What are the key properties of rat IL-9 for experimental planning?

Table 1: Physical and Biochemical Properties of Rat IL-9

PropertyCharacteristicsReference
Molecular Weight20-30 kDa (glycosylated form)
Basic Structure144 amino acid precursor with 18 amino acid signal peptide
Gene ID116558
Gene SymbolIl9
Protein AliasesILN, Interleukin, Interleukin9, interleukin-9
Primary Producing CellsActivated Th2 lymphocytes, TH9 cells

What factors influence TH9 cell differentiation and IL-9 production?

Table 2: Regulators of TH9 Differentiation and IL-9 Production

FactorEffect on TH9/IL-9 ProductionExperimental ContextReference
TGF-β + IL-4Stimulates differentiation of naive CD4 T cells into TH9 cellsIn vitro polarization
IL-1βEnhances TH9 differentiationInflammatory conditions
TNF-αEnhances TH9 differentiationInflammatory conditions
cGAMP (STING agonist)Potentially enhances TH9 functionPre-treatment before polarization
PMA + Ca2+ ionophoreStimulates IL-9 expression for detectionFlow cytometry preparation

How should I design experiments to study IL-9 functions in rat models?

Table 3: Experimental Approaches for Studying IL-9 in Rats

Research QuestionMethodological ApproachKey Controls/ConsiderationsReference
IL-9 protein detectionELISA (serum, plasma, cell supernatant)Include standards for quantification
Intracellular IL-9 detectionFlow cytometry with anti-IL-9 antibodiesIsotype controls, cell stimulation with PMA/ionophore
IL-9 neutralizationAnti-IL-9 neutralizing antibodiesRat IgG1 isotype control (clone HRPN)
IL-9 function in cancerAdoptive transfer of TH9 cellsTumor measurement protocols, appropriate tumor models
IL-9 production regulationSTING pathway manipulationSTING knockout or activation models

What are the promising new areas of rat IL-9 research?

Emerging areas in rat IL-9 research include:

  • Further exploration of the role of STING signaling in controlling TH9 cell differentiation and IL-9 production

  • Investigation of the mechanisms by which IL-9-producing cells mediate antitumor immunity and how this can be enhanced

  • Development of more sophisticated genetic models to study IL-9 function in vivo

  • Examination of IL-9's role in neuroinflammation and potential neuroimmune interactions

  • Exploration of IL-9 as a therapeutic target or agent in various disease contexts

How might epigenetic regulation influence IL-9 expression in rats?

While the search results don't directly address epigenetic regulation of IL-9, this represents an important frontier in cytokine research. Investigators might consider:

  • Examining histone modifications at the Il9 locus during TH9 cell differentiation

  • Investigating DNA methylation patterns that correlate with IL-9 expression

  • Studying the role of microRNAs in post-transcriptional regulation of IL-9

  • Exploring how environmental factors might induce epigenetic changes affecting IL-9 production

  • Comparing epigenetic signatures between different IL-9-producing cell populations

What translational potential exists for rat IL-9 research findings?

Findings from rat IL-9 research have several potential translational applications:

  • Development of IL-9-based or IL-9-targeting therapeutics for cancer immunotherapy, given the potent antitumor properties of IL-9-producing TH9 cells

  • Exploration of the essential role of IL-9 in the efficacy of dendritic cell vaccination and anti-GITR therapy, suggesting combination approaches for enhanced cancer treatment

  • Investigation of IL-9 manipulation for allergic and inflammatory conditions, given its role in regulating cells involved in asthma responses

  • Consideration of the TGF-β/IL-9 axis as a therapeutic target in various disease contexts

Product Science Overview

Structure and Function

IL-9 is a member of the type I cytokine receptor family. The IL-9 receptor (IL-9R) is a protein that specifically mediates the biological effects of IL-9. The receptor is composed of two subunits: the IL-9R alpha subunit and the common gamma chain (γc). The binding of IL-9 to its receptor leads to the activation of various signaling pathways, including the JAK/STAT pathway, which is crucial for transmitting signals from the cell surface to the nucleus .

Recombinant IL-9

Recombinant IL-9 refers to IL-9 that is produced through recombinant DNA technology. This involves inserting the gene encoding IL-9 into a host cell, such as bacteria or yeast, which then produces the cytokine. Recombinant IL-9 is used in research to study its effects on various cell types and to understand its role in diseases such as asthma and allergies .

Applications in Research

Recombinant rat IL-9 is particularly useful in research involving rodent models. It is used to study the effects of IL-9 on rat immune cells and to investigate the potential therapeutic applications of IL-9 in treating diseases. For example, recombinant rat IL-9 can be used to study its role in mast cell maturation and the enhancement of IgE production by B cells .

Stability and Storage

Recombinant proteins, including IL-9, are typically provided as lyophilized powders. They are stable for up to twelve months when stored at -20°C to -80°C. It is recommended to aliquot the protein to avoid repeated freeze-thaw cycles, which can degrade the protein .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.